The frequency of missed breast cancers in women participating in a high-risk MRI screening program

AbstractPurposeTo evaluate the frequency of missed cancers on breast MRI in women participating in a high-risk screening program.MethodsPatient files from women who participated in an increased risk mammography and MRI screening program (2003 –2014) were coupled to the Dutch National Cancer Registry. For each cancer detected, we determined whether an MRI scan was available (0–24 months before cancer detection), which was reported to be negative. These negative MRI scans were in consensus re-evaluated by two dedicated breast radiolog ists, with knowledge of the cancer location. Cancers were scored as invisible, minimal sign, or visible. Additionally, BI-RADS scores, background parenchymal enhancement, and image quality (IQ; perfect, sufficient, bad) were determined. Results were stratified by detection mode (mammography, MRI, in terval cancers, or cancers in prophylactic mastectomies) and patient characteristics (presence ofBRCA mutation, age, menopausal state).ResultsNegative prior MRI scans were available for 131 breast cancers. Overall 31% of cancers were visible at the initially negative MRI scan and 34% of cancers showed a minimal sign. The presence of aBRCA mutation strongly reduced the likelihood of visible findings in the last negative MRI (19 vs. 46%,P 
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research

Related Links:

Studies have demonstrated increased breast cancer risk associated with postmenopausal hormone therapy, but does risk vary depending on dose, formulation, and route of delivery of estrogen-alone HT?Menopause
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news
Source: Nutrition and Cancer - Category: Cancer & Oncology Authors: Source Type: research
(The North American Menopause Society (NAMS)) Vitamin D is already well known for its benefits in building healthy bones. A new study supports the idea that it also may reduce cancer risk as well as breast cancer mortality, especially in women with a lower body mass index. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS).
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
ConclusionsOur findings showed that an unhealthy dietary pattern might be associated with higher risk of breast among Iranian women.
Source: European Journal of Obstetrics and Gynecology and Reproductive Biology - Category: OBGYN Source Type: research
Objective: Approximately 50% to 70% of breast cancer survivors are affected by one or more symptoms of vulvovaginal atrophy (VVA). For those who cannot take hormone therapy, autologous platelet-rich plasma combined with hyaluronic acid (A-PRP-HA) may provide a new alternative therapy for the treatment of VVA in postmenopausal women with history of breast cancer. Methods: We enrolled 20 postmenopausal breast cancers survivors with VVA and a score of
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
No abstract available
Source: Menopause - Category: OBGYN Tags: Erratum Source Type: research
You may have to cope with an altered body image and a treatment-induced menopause, but don ’t let cancer take away your physical connection, says Dr Liz O'Riordan, who was diagnosed in 2015.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
ConclusionsPhysical activity is not a determinant of MD.
Source: Cancer Causes and Control - Category: Cancer & Oncology Source Type: research
Condition:   Breast Neoplasms Interventions:   Drug: Xentuzumab;   Drug: Placebo;   Drug: Everolimus;   Drug: Exemestane Sponsor:   Boehringer Ingelheim Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Conclusions: This study identified the predictors of new-onset psychological distress available in routinely collected administrative health databases, and showed how predictors change between hospital-based treatment and transitional survivorship periods. The results highlight the importance of developing predictive models tailored to the period of cancer care. PMID: 30181418 [PubMed - in process]
Source: Journal of the National Comprehensive Cancer Network : JNCCN - Category: Cancer & Oncology Tags: J Natl Compr Canc Netw Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Mammography | Mastectomy | Men | Menopause | Netherlands Health | PET Scan | Study | Women